WILMINGTON – Growing Wilmington-area biopharmaceutical firm Incyte has agreed to acquire a North Carolina-based firm working on a new treatment for the skin pigmentation disorder vitiligo in a deal worth […]
WILMINGTON – Incyte secured on Monday the first U.S. Food & Drug Administration approval for a treatment of the skin pigmentation disorder vitiligo, demonstrating the growing strength of the biopharmaceutical […]
© 2023 Delaware Business Times